• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,470.11 -238.41
( -0.31%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,580.59 55.83
(0.53%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Avience Biomedicals Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
94324
INE0V9I01017
157.0914426
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AVIENCE
21.32
143.63
EPS(TTM)
Face Value()
Div & Yield %
12.28
10
0
 

Sundaram Brake Linings appoints Hari S as CFO
Mar 09,2026
Hari S is a Fellow Chartered Accountant (FCA) with 30+ years of experience in finance, accounts, banking, taxation, project finance, and corporate financial management. He has served as GM (F&A) at NTADCL and Chief Finance Manager at ITI Limited, leading financial restructuring, consortium banking, fundraising, statutory compliance, and board-level reporting. Hari has extensive experience in corporate debt restructuring, multi-bank consortium management, and complex financial negotiations, with a proven record of turnaround management, profitability improvement, and strategic financial oversight across listed entities and large infrastructure projects.

Sundaram Brake Linings manufactures asbestos-free friction materials.

The company reported a standalone net loss of Rs 1.24 crore in Q3 FY26, compared with a net profit of Rs 0.89 crore recorded in Q3 FY25. Revenue from operations for the period under review declined 4.7% year-on-year (YoY) to Rs 84.19 crore.

Shares of Sundaram Brake Linings fell 3.45% to close at Rs 560 on the BSE.